Skip to content
Precision for Medicine
Contact Us
Press Release

FDA Veteran Paz Vellanki, MD, joins Precision to become one of 3 ex-FDA oncology leaders supporting clients

Read the release
ring-the-bel-3l

Life-changing therapies
without a lifetime of
development

Precision for Medicine solves the most complex clinical development challenges to bring innovative therapies to patients. Contact Us

No one who is working to help patients in need should be subjected to unnecessary delays during clinical development and commercialization. Precision’s integrated capabilities, responsive operations and deep scientific expertise are helping life science innovators accelerate research and development while reducing cost and increasing the probability of approval.

Specialized capabilities for every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Precision brings a holistic view to your program's unique needs.

  • Discover Explore
    clinical-trial-support

    Global CRO
    Services

    Award-winning CRO with deep oncology and rare disease expertise

    Explore
  • Discover Explore
    specialty-lab-services

    Global Laboratory
    Services

    Exceptional translational and biomarker sciences with global clinical logistics services

    Explore
  • Discover Optimize early phase development
    Optimize early phase development

    Optimize early phase development

    How can you successfully navigate the complexities of early phase development? Integrated clinical and laboratory sciences capabilities are vital. Over 25 years of experience in early oncology development helps anticipate and mitigate a diverse set of risks, including complicated kitting and sample management.

    Discover
  • Discover Maximize late phase development
    Maximize late phase development

    Maximize late phase development

    Congratulations if you are entering late phase development. Now you’ll need a partner that can recruit patients most likely to respond to treatment, manage complex protocols, anticipate global regulatory requirements, enable manufacturing, support commercial viability and more. Let us drive your innovation to market and empower access for patients.

    Discover
human-

Trusted partner to leading innovators in oncology and rare disease

Clinical development is growing more complicated. Progress can hinge on the ability to navigate a shifting pathway to approval. Your path may be unique from those who have gone before, but our experience will help inform success. Precision is a leader in oncology and rare disease research. Our deep experience in complex indications accelerates the ability to reach key milestones, drive positive outcomes and most importantly, help patients get access to innovative treatments.

Contact us
70 of clinical trials are in oncology
2500 clinical trial and lab projects
5 specialty labs in the US and Europe
30 in investments raised for biotech in the last 5 years
CRO Winner Badge@2x

Winner of the 2025 Fierce Biotech CRO Award for Innovative Solutions in Drug Development

Precision is dedicated to operational excellence and our collaborative approach to tackling complex challenges in oncology and rare disease research.

This recognition highlights our successful rescue of a high-risk hematology-oncology trial, where we conducted a full operational and data gap analysis, rebuilt sponsor alignment through proactive collaboration, implemented centralized patient-level data monitoring, and developed custom tracking systems to accelerate regulatory and startup activities.

We’re proud to help advance critical therapies and grateful to the sponsors, investigators, and teams who make this work possible.

Read Press Release

Deep experience with debilitating disease and unique modalities

Like you, we understand that there’s a patient throughout the development pathway. Supporting our partners to bring innovative treatments to patients is our purpose. Leverage our experience in these therapeutic areas.

Oncology Explore Rare Diseases Explore Autoimmune Explore Gene Therapy Explore Cell Therapy Explore

  • People first and patient-focused

    One of our core values is service. Not just to our clients but to our communities. Volunteering at hospitals, supporting healthcare-related fund raisers and partnering with nonprofit organizations is an integral part of our culture. In doing so, we raise awareness of many life-altering diseases and our team gets closer to the actual patients that can be impacted by our work. 

  • People first and patient-focused

    One of our core values is service. Not just to our clients but to our communities. Volunteering at hospitals, supporting healthcare-related fund raisers and partnering with nonprofit organizations is an integral part of our culture. In doing so, we raise awareness of many life-altering diseases and our team gets closer to the actual patients that can be impacted by our work. 

  • People first and patient-focused

    One of our core values is service. Not just to our clients but to our communities. Volunteering at hospitals, supporting healthcare-related fund raisers and partnering with nonprofit organizations is an integral part of our culture. In doing so, we raise awareness of many life-altering diseases and our team gets closer to the actual patients that can be impacted by our work. 

Insights for the greater good

We feel privileged to work in an industry that can change lives. When knowledge is shared, it is amplified. Expanding our collective intelligence can bring remedies to market faster. 

Explore More
Read: Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs

Translational Research

Case Study: Nectin 4 Biomarker Testing for Oncology Clinical Programs

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=219184495938, hs_child_table_id=0, hs_updated_at=1786473626295, hs_published_at=1788379322226, description=Christie Bongel is a scientist by training, but her true passion lies in leadership, particularly in building leaders and shaping high-performing, trust-based cultures. She believes that many talented bench scientists are promoted into management roles without formal leadership development and is committed to helping close that gap. While culture and people development may not always appear on a balance sheet, she views them as essential drivers of long-term organizational success. As a leadership-focused operations executive, Christie leads laboratory operations and strategy within a global network, partnering with pharmaceutical and biotechnology organizations to navigate complex oncology challenges. Her work spans translational oncology, clinical trial strategy, and laboratory execution, with a focus on translating scientific and operational complexity into clear, actionable strategies that drive meaningful outcomes., avatar=Image{width=800,height=800,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/1781614819314.png',altText='Christie Bongel',fileId=219203862915}, lastname=Bongel, hs_initial_published_at=1786473638412, hs_created_by_user_id=65712240, hs_created_at=1786473568408, hs_is_edited=false, hs_deleted_at=0, name=Christie, job=Site Director, slug=christie-bongel, hs_updated_by_user_id=65712240}, second={}, third={}})
  • Christie Bongel avatar

    Christie Bongel
Discover
Read: Has the rest of the world finally caught up with Latin America? Has the rest of the world finally caught up with Latin America?

Clinical Trials

Has the rest of the world finally caught up with Latin America?

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=220405672474, hs_child_table_id=0, hs_updated_at=1788379304461, hs_published_at=1788379322226, description=Andrés Bayona, MD, MBA, is a tenured physician and healthcare executive with over 30 years of experience spanning clinical practice, healthcare management, and global clinical research operations. He holds a specialization in Internal Medicine, as well as advanced degrees in Health Services Management and an MBA. In his role as VP, Clinical Operations, his many years in CRO and global Pharma roles and deep connections within the Latin American healthcare industry make him uniquely qualified to guide our growth strategy in Latin America., avatar=Image{width=240,height=360,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Bayona_Andres_1445.jpg',altText='Bayona_Andres_1445',fileId=220973350833}, lastname=Bayona, hs_initial_published_at=1787769344448, hs_created_by_user_id=65712240, hs_created_at=1787769297292, hs_is_edited=false, hs_deleted_at=0, name=Andrés, job=Vice President, Clinical Operations, slug=andres-bayona, hs_updated_by_user_id=65712240}, second={}, third={}})
  • Andrés Bayona avatar

    Andrés Bayona
Discover
Read: Case Study: Rapid Execution of Assay Validation Rescued Global Study Case Study: Rapid Execution of Assay Validation Rescued Global Study

Translational Research - Assays

Case Study: Rapid Execution of Assay Validation Rescued Global Study

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=219184495938, hs_child_table_id=0, hs_updated_at=1786473626295, hs_published_at=1788379322226, description=Christie Bongel is a scientist by training, but her true passion lies in leadership, particularly in building leaders and shaping high-performing, trust-based cultures. She believes that many talented bench scientists are promoted into management roles without formal leadership development and is committed to helping close that gap. While culture and people development may not always appear on a balance sheet, she views them as essential drivers of long-term organizational success. As a leadership-focused operations executive, Christie leads laboratory operations and strategy within a global network, partnering with pharmaceutical and biotechnology organizations to navigate complex oncology challenges. Her work spans translational oncology, clinical trial strategy, and laboratory execution, with a focus on translating scientific and operational complexity into clear, actionable strategies that drive meaningful outcomes., avatar=Image{width=800,height=800,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/1781614819314.png',altText='Christie Bongel',fileId=219203862915}, lastname=Bongel, hs_initial_published_at=1786473638412, hs_created_by_user_id=65712240, hs_created_at=1786473568408, hs_is_edited=false, hs_deleted_at=0, name=Christie, job=Site Director, slug=christie-bongel, hs_updated_by_user_id=65712240}, second={hs_id=159488778874, hs_child_table_id=0, hs_updated_at=1765824406763, hs_published_at=1788379322226, description=Kennon Daniels is a scientific and regulatory in vitro diagnostic authority, specializing in the development of US regulatory strategies and FDA marketing submissions for IVD assays and instruments. Her expertise spans all aspects of product development, analytical and clinical trial protocol designs, Q-Submissions, IDEs, de novos, 510(k)s, and pre-market approval platforms., avatar=Image{width=576,height=576,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Kennon%20Daniels.webp',altText='Kennon Daniels',fileId=165893120790}, linkedin=https://www.linkedin.com/in/kennon-daniels-ph-d-84a90b6, hs_name=, hs_path=, lastname=Daniels, PhD, hs_initial_published_at=1775839468505, hs_created_at=1709645745105, hs_is_edited=false, hs_deleted_at=0, name=Kennon, position=Vice President, IVD Regulatory Consulting, job=, slug=kennon-daniels, email=, hs_updated_by_user_id=65712240}, third={}})
  • Christie B. avatar

    Christie B.
  • Kennon D. avatar

    Kennon D.
Discover